Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Heather
Contact Heather, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Splitting apheresis platelets as a contingency measure for inventory shortages
CONFLICT OF INTEREST STATEMENT EMB reports personal fees and nonfinancial support from Grifols, Abbott, UpToDate, Tegus, and Health Advances outside of the submitted work. EMB is a co-investigator on a US government funded clinical trial evaluating Mirasol Pathogen Reduction Technology. REFERENCES 1, , , , , , et al. Evaluating apheresis platelets at reduced dose as a contingency measure for extreme shortages. Transfusion. 2022; 62: 173–182. https://doi.org/10.1111/trf.16723 2, , , , .
Reevaluation of the medical necessity of washed red blood cell transfusion in chronically transfused adults
Background Washing red blood cell (RBC) units mitigates severe allergic transfusion reactions. However, washing reduces the time to expiration and the effective dose. Automated washing is time- and labor-intensive. A shortage of cell processor tubing sets prompted review of medical necessity for washed RBC for patients previously thought to require washing. Study Design and Methods A single-center, retrospective study investigated discontinuing wash RBC protocols in chronically transfused adults.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Heather
Contact Heather, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack